Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Vericel Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +26 vs. Q4 2022
- Shares held
- 50.4M
- +332.9K (+0.7%) vs. Q4 2022
- Total value
- $1.48B
- +$160.2M (+12.2%) vs. Q4 2022
- New holders
- 41
- 67 more added
- Sold out
- 15
- 63 more reduced
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $2.47B |
| Q1 2026 | 280 | $1.78B |
| Q4 2025 | 274 | $1.93B |
| Q3 2025 | 249 | $1.67B |
| Q2 2025 | 273 | $2.35B |
| Q1 2025 | 277 | $2.39B |
| Q4 2024 | 278 | $2.87B |
| Q3 2024 | 268 | $2.15B |
| Q2 2024 | 261 | $2.32B |
| Q1 2024 | 257 | $2.68B |
| Q4 2023 | 227 | $1.84B |
| Q3 2023 | 214 | $1.73B |
| Q2 2023 | 202 | $1.88B |
| Q1 2023 | 200 | $1.48B |
| Q4 2022 | 178 | $1.32B |
| Q3 2022 | 180 | $1.21B |
| Q2 2022 | 183 | $1.34B |
| Q1 2022 | 197 | $2.01B |
| Q4 2021 | 185 | $2.04B |
| Q3 2021 | 202 | $2.48B |
| Q2 2021 | 205 | $2.57B |
| Q1 2021 | 205 | $2.75B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Vericel Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −783,225−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,052−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,147−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −9,131−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −7,887−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −7,675−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −4,138−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |
| Cornerstone Planning Group LLC | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |
| Tyler-Stone Wealth Management | – | – | – | – | Not filed |